Van Leeuwenhoek do this analysis for a fee. That doesn't mean that they are not being objective. A lot of the recent information has been lifted from Invion presentations and is nothing new. You will notice they cover a number of other small Aussie biotechs eg OSL, CDY, POH ( Greg Collier a director). POH has a market cap or 13 m ( most of which is cash sitting in the bank) and Van L value you the company in excess of 100m. Non of these companies release these reports to the ASX , they are more directed to jittery retail shareholders. Van L actually ran the same headline for Benitec in 2013 ' moving to a higher gear'- which it hasn't.
I am very confident in the forthcoming flow of news from the company.
IVX Price at posting:
0.9¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)